Skip to Main Content
Pharmacy Technician's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Opioid Resources
    • Transitions of Care Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • National Certification
    • Additional Requirements
    • Exemptions
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Gastroenterology
  4. Liver Disease
  5. Monitoring

Monitoring

  • Bowel Preps (10)
  • Celiac Disease (4)
  • Constipation (53)
  • Crohn's Disease (4)
  • Diarrhea (54)
  • Gastrointestinal Bleeding (103)
  • GERD (77)
  • Heartburn (16)
  • Hemorrhoids (4)
  • Inflammatory Bowel Disease (10)
  • IBS (16)
  • Liver Disease (100)
    • Hepatitis B (1)
    • Hepatitis C (47)
    • Natural Medicines / Supplements (10)
    • Drug-Induced Liver Disease (48)
    • Monitoring (11)
  • Nausea & Vomiting (48)
  • Other (95)
  • Peptic Ulcer Disease (48)
  • Resources (107)
  • Ulcerative Colitis (2)
  • Ulcers (5)
1 - 11 of 11 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Lab Monitoring for Common Medications May 2021
Chart: Using Common Medications in Liver Impairment April 2021
Chart: Hepatitis C Treatment Overview July 2019
Chart: Characteristics of the Various Statins June 2016
Article: Keep Harvoni for Hepatitis C in its Original Container December 2014
Chart: Liver Function Test Scheduling June 2014
Article: myths about using certain meds in patients with chronic liver disease (cirrhosis, hepatitis, etc) October 2013
Article: patients on statins (atorvastatin, simvastatin, etc) will get fewer liver function lab tests May 2012
Article: Xifaxan (rifaximin) now comes in a 550 mg tablet June 2010
Commentary: Rifaximin (Xifaxan) for Hepatic Encephalopathy June 2010
Article: risk of renal impairment in patients taking an ACE inhibitor or ARB, diuretic, and NSAID December 2006
  • 1
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
© Therapeutic Research Center. All Rights Reserved